| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 40 |
| 1 | FUROSEMIDE | 37 |
| 2 | ACETAMINOPHEN | 35 |
| 3 | ACETAMINOPHEN 500MG | 33 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 33 |
| 5 | PAIN RELIEVER | 33 |
| 6 | TACROLIMUS | 33 |
| 7 | LENVATINIB | 32 |
| 8 | PREDNISOLONE | 32 |
| 9 | PREDNISOLONE ORAL | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROVALIMAB | 1 | 0.0083 |
| 1 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 2 | COSYNTROPIN | 1 | 0.0045 |
| 3 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 4 | ETHIODIZED OIL | 5 | 0.0039 |
| 5 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 6 | SELADELPAR LYSINE | 1 | 0.0036 |
| 7 | NITAZOXANIDE | 1 | 0.0029 |
| 8 | SODIUM GLYCEROPHOSPHATE | 1 | 0.0027 |
| 9 | MEGNESIUM OXIDE | 1 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 87 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 75 |
| 2 | Kinase Inhibitor [EPC] | 72 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63 |
| 4 | Proton Pump Inhibitor [EPC] | 45 |
| 5 | Platinum-based Drug [EPC] | 39 |
| 6 | Loop Diuretic [EPC] | 38 |
| 7 | GLP-1 Receptor Agonist [EPC] | 33 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 31 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 4 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 5 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 6 | Bile Acid [EPC] | 25 | 0.0011 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 21 | 0.0010 |
| 8 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |